Skip to main content

Table 2 Pharmacotherapeutic prescriptions by general practitioners for patients with angina pectoris within 3 months after diagnosis

From: Non-acute chest pain in primary care; referral rates, communication and guideline adherence: a cohort study using routinely collected health data

  

Number of patients (%)

Total

Referred

Not referred

p-value*

New diagnosis of angina pectoris

255

(100)

114

(45)

141

(55)

 

 Antiplatelet therapy

193

(76)

98

(86)

95

(67)

0.001

     Acetylsalicylic acid/ Carbasalate calcium

187

(73)

95

(83)

92

(65)

0.001

     Clopidogrel

57

(22)

35

(31)

22

(16)

0.004

  Ticagrelor

18

(7)

7

(6)

11

(8)

0.634

  Dipyridamol

3

(1)

1

(1)

2

(1)

1.000

  Prasugrel

3

(1)

0

(0)

3

(2)

0.255

 No antiplatelet therapy

62

(24)

16

(14)

46

(33)

 

  Vitamin K antagonist (VKA)

24

(39)

4

(25)

20

(43)

0.242

  DOAC

1

(1)

0

(0)

1

(2)

1.000

  No DOAC or VKA

37

(60)

12

(75)

25

(54)

0.237

 Statin therapy

186

(73)

95

(83)

91

(65)

0.001

 Antihypertensive therapy

240

(94)

109

(96)

131

(93)

0.361

  Beta-blockers

188

(74)

91

(80)

97

(69)

0.047

  Diuretics

67

(26)

25

(22)

42

(30)

0.156

  Calcium channel blocker

66

(26)

32

(28)

34

(24)

0.473

  Renin-angiotensin blocking agents

146

(57)

70

(61)

76

(54)

0.229

  Nitrates

151

(59)

71

(62)

80

(57)

0.371

  1. *p < 0.05 is considered significant